Found 13 matching trials
AZD9668 Relative Bioavailability PHASE1 This clinical study will aid future formulation development and optimisatio...
Show More Learn More & Join Trial
Single Oral Dose of 60 mg [14C]AZD9668 in Healthy Male Volunteers PHASE1 The purpose of the study is to characterise the absorption, distribution, m...
Show More Learn More & Join Trial
A Phase II , Placebo-controlled Study to Assess Efficacy of 28 Day Oral AZD9668 in Patients With Bronchiectasis PHASE2 The purpose of this study is to investigate if treatment with AZD9668 for 2...
Show More Learn More & Join Trial
Effect on Structural Changes in Airways, Measured by MSCT, of Twice Daily 60mg AZD9668 for 12 Weeks in Chronic Obstructive Pulmonary Disease (COPD) Patients PHASE2 The primary objective of the study is to evaluate structural changes effect...
Show More Learn More & Join Trial
A 12-week Study Treating Participants Who Have alpha1-antitrypsin-related COPD With Alvelestat (MPH966) or Placebo. PHASE2 The purpose of this study is to investigate the effect of alvelestat (an or...
Show More Location
University of Alabama, Birmingham (UAB)
Learn More & Join Trial
Efficacy and Safety of Twice Daily 60mg AZD9668 in COPD for 12 Weeks in Patients on Background Budesonide/Formoterol PHASE2 The primary objective is to evaluate the efficacy of AZD9668 compared with ...
Show More Learn More & Join Trial
Phase I, Exploratory, Single Centre, Single Oral Dose AZD9668 and Intravenous Microdose of [C14] AZD9668, Healthy Subject PHASE1 The primary objective of this study is to assess the absolute bioavailabili...
Show More Learn More & Join Trial
Anti-Inflammatory Small Drug Adjunctive Therapy for Type 2 Diabetes PHASE2 The role of individual leukocyte populations in type 2 diabetes (T2D) and i...
Show More Location
Allegheny Health Network
Learn More & Join Trial
A Phase II , Placebo-controlled Study to Assess Efficacy of 28 Day Oral AZD9668 in Patients With Cystic Fibrosis PHASE2 The purpose of this study is to investigate if treatment with AZD9668 for 2...
Show More Learn More & Join Trial
A Dose Range Finding Study to Evaluate the Efficacy and Safety of AZD9668 Administered Orally at Three Dose Levels to Patients With Chronic Obstructive Pulmonary Disease (COPD) on Treatment With Tiotropium PHASE2 The primary objective is to evaluate the dose-response relationship and eff...
Show More Learn More & Join Trial